Cronos Group (NASDAQ:CRON) Hits New 12-Month Low – Time to Sell?

Cronos Group Inc. (NASDAQ:CRON) hit a new 52-week low on Monday . The stock traded as low as $1.78 and last traded at $1.82, with a volume of 2332484 shares traded. The stock had previously closed at $1.82.

Cronos Group Price Performance

The company has a market capitalization of $698.12 million, a price-to-earnings ratio of -14.12, a price-to-earnings-growth ratio of 1.74 and a beta of 0.89. The business has a fifty day moving average price of $1.94 and a 200 day moving average price of $2.04.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Thompson Davis & CO. Inc. bought a new position in Cronos Group during the fourth quarter valued at about $29,000. Tower Research Capital LLC TRC boosted its stake in Cronos Group by 140.5% during the fourth quarter. Tower Research Capital LLC TRC now owns 13,726 shares of the company’s stock valued at $28,000 after buying an additional 8,019 shares in the last quarter. SBI Securities Co. Ltd. bought a new position in Cronos Group during the fourth quarter valued at about $30,000. Jones Financial Companies Lllp boosted its stake in Cronos Group by 64.5% during the fourth quarter. Jones Financial Companies Lllp now owns 16,623 shares of the company’s stock valued at $34,000 after buying an additional 6,520 shares in the last quarter. Finally, Quantbot Technologies LP acquired a new position in shares of Cronos Group in the 3rd quarter valued at $37,000. Institutional investors own 8.71% of the company’s stock.

About Cronos Group

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.